Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veliparib in BRCA-mutated recurrent ovarian cancer
NCT01472783Phase 2Completed
- Sponsor
- Vejle Hospital
- Start
- Nov 2011
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of veliparib in epithelial ovarian cancer (EOC), fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Vejle Hospital. Started Nov 2011; status: completed.
02
Drugs
veliparib
03
Conditions
epithelial ovarian cancer (EOC)fallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT01472783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01472783.